Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein

Infection with Respiratory Syncytial Virus (RSV) causes both upper and lower respiratory tract disease in humans, leading to significant morbidity and mortality in both young children and older adults. Currently, there is no licensed vaccine available, and therapeutic options are limited. During the...

Descripción completa

Detalles Bibliográficos
Autores principales: Flynn, Jessica A., Durr, Eberhard, Swoyer, Ryan, Cejas, Pedro J., Horton, Melanie S., Galli, Jennifer D., Cosmi, Scott A., Espeseth, Amy S., Bett, Andrew J., Zhang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072732/
https://www.ncbi.nlm.nih.gov/pubmed/27764150
http://dx.doi.org/10.1371/journal.pone.0164789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072732/
https://www.ncbi.nlm.nih.gov/pubmed/27764150
http://dx.doi.org/10.1371/journal.pone.0164789

Ejemplares similares